Limbic-predominant age-related TDP-43 encephalopathy

LATE neuropathologic changes (LATE-NC). A normal centenarian brain, cut in the coronal plane (top left) is compared to a brain with LATE-NC (top right). The hippocampi on both sides are atrophic (shrunken) in the brain with LATE-NC. The bottom 3 panels show photomicrographs of a hippocampus with LATE-NC, stained for phosphorylated TDP-43 protein (TDP-43). Insets show TDP-43 positive neuronal cytoplasmic inclusions (Inset A--in dentate granule cells) and wispy non-tapering cellular processes stained for TDP-43 protein (Inset B--in CA1).

Limbic-predominant age-related TDP-43 encephalopathy (LATE) is a term that describes a prevalent condition with impaired memory and thinking in advanced age, often culminating in the dementia clinical syndrome.[1] In LATE, there is a buildup of misfolded TDP-43 protein in the brain, especially in the amygdala and hippocampus, and the disease typically affects persons older than 75 years of age (with some exceptions; please see below).

As of December 2021, LATE can only be diagnosed with certainty at autopsy. The terminology used to refer to the brain changes identified in autopsy-confirmed LATE is: LATE neuropathologic change (LATE-NC).

LATE is a very common condition, with autopsy studies around the world indicating that LATE-NC is present in the brains of about a quarter of people over 85.[1] LATE-NC is often comorbid with (i.e., occurs in the same brain as) other pathologic changes that are associated with dementia, such as Alzheimer's disease and cerebrovascular disease(s).

LATE has a large impact on public health. Clinical-pathologic correlation studies have established that the presence of LATE-NC in the brain is associated with impairments in memory and thinking.[1] In older persons whose brains lack Alzheimer's disease-type amyloid plaques and neurofibrillary tangles, the presence of LATE-NC at autopsy is associated with a relatively slow cognitive decline (in comparison with Alzheimer's disease), mostly affecting the memory domain.[2] However, most people (~75%) beyond age 85 have some Alzheimer's disease-type pathology and in this common scenario the impact of LATE-NC is very important.[3] Approximately one-half of persons with Alzheimer's disease pathology also have LATE-NC.[4][5][6] In these persons, the presence of LATE-NC is associated with a swifter disease course and with more severe clinical (memory and thinking) impairment than when only Alzheimer's disease pathology is present.[7][8][9][2] A common combination of brain pathologies—with Alzheimer's disease pathology, Lewy body pathology, and LATE-NC in the same brain—tends to affect younger individuals (often <75 yrs of age) and, on average, is associated with more aggressive (faster) cognitive deterioration.[10][11] With or without co-existing Alzheimer's disease pathology or other brain changes, persons with LATE-NC generally lack the clinical features of frontotemporal dementia (FTD).[12][13]

For reasons that are presently unknown, the disease process of LATE-NC preferentially affects medial temporal lobe structures of the brain, particularly the amygdala and hippocampus.[14] In a significant proportion of persons with LATE-NC, there is atrophy, cell loss and astrogliosis in the hippocampus, diagnosable at autopsy (and somewhat less specifically via MRI during life) as hippocampal sclerosis.[15] Brains with LATE-NC and hippocampal sclerosis are relatively more affected clinically than those with LATE-NC alone.[16] The phenomenon of hippocampal sclerosis-linked dementia, as well as the link to TDP-43, were first described by Dr. Dennis Dickson and colleagues,[17][15] and this clinical-pathologic entity was subsequently confirmed by many others.[18][19][20][21][22] However, brain changes diagnosable as "hippocampal sclerosis" is/are also seen in other diseases (such as epilepsy), and many LATE-NC brains lack full-blown hippocampal sclerosis, so, hippocampal sclerosis is neither a sensitive nor specific feature of LATE-NC.[1]

The major known risk factors for LATE-NC are genetic: variations in the TMEM106B, GRN, APOE, ABCC9, KCNMB2, and WWOX genes have been linked to altered risk for LATE-NC (and/or hippocampal sclerosis dementia).[1][23][24][25][26][27][28][29]

There currently is no known cure or preventative strategy for LATE-NC.

The deleterious impact(s) of TDP-43 proteinopathy may influence the brain via a number of different mechanisms. In normal brains and other tissues, the TDP-43 protein helps to ensure proper functioning of genes in the cell; the misfolded TDP-43 may thus impair normal gene expression regulation (so in LATE-NC, there is a loss-of-normal-function), and, the aberrant TDP-43 protein in LATE-NC may induce toxic gains of function also.[30][31]

TDP-43 proteinopathy (a disease-associated phenomenon discovered by Dr. Manuela Neumann and colleagues at UPENN in the Drs John Trojanowski/Virginia Lee CNDR Lab[32]) is also implicated in frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS), and other diseases.[33][34][32]

References

  1. 1 2 3 4 5 Nelson, Peter T; Dickson, Dennis W; Trojanowski, John T; Boyle, Patricia A; Arfanakis, Konstantinos; Rademakers, Rosa; Alafuzoff, Irina; Attems, Johannes; Brayne, Carol; Coyle-Gilchrist, Ian T S; Chui, Helena C; Fardo, David W; Flanagan, Margaret E; Halliday, Glenda; Hokkanen, Suvi R K; Hunter, Sally; Jicha, Gregory A; Katsumata, Yuriko; Kawas, Claudia H; Keene, C Dirk; Kovacs, Gabor G; Kukull, Walter A; Levey, Allan I; Makkinejad, Nazanin; Montine, Thomas J; Murayama, Shigeo; Murray, Melissa E; Nag, Sukriti; Rissman, Robert A; Seeley, William W; Sperling, Reisa A; White III, Charles L; Yu, Lei; Schneider, Julie A (30 April 2019). "Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report". Brain. Online first (6): 1503–1527. doi:10.1093/brain/awz099. PMC 6536849. PMID 31039256.
  2. 1 2 Nag, Sukriti; Yu, Lei; Wilson, Robert S.; Chen, Er-Yun; Bennett, David A.; Schneider, Julie A. (2017-02-14). "TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD". Neurology. 88 (7): 653–660. doi:10.1212/WNL.0000000000003610. ISSN 1526-632X. PMC 5317379. PMID 28087828.
  3. Braak, Heiko; Thal, Dietmar R.; Ghebremedhin, Estifanos; Del Tredici, Kelly (November 2011). "Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years". Journal of Neuropathology and Experimental Neurology. 70 (11): 960–969. doi:10.1097/NEN.0b013e318232a379. ISSN 1554-6578. PMID 22002422. S2CID 739734.
  4. Buciuc, Marina; Wennberg, Alexandra M.; Weigand, Stephen D.; Murray, Melissa E.; Senjem, Matthew L.; Spychalla, Anthony J.; Boeve, Bradley F.; Knopman, David S.; Jack, Clifford R.; Kantarci, Kejal; Parisi, Joseph E. (2020). "Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes". Journal of Alzheimer's Disease. 73 (4): 1511–1523. doi:10.3233/JAD-191040. ISSN 1875-8908. PMC 7081101. PMID 31929165.
  5. Nag, Sukriti; Barnes, Lisa L.; Yu, Lei; Wilson, Robert S.; Bennett, David A.; Schneider, Julie A. (2020-10-13). "Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents". Neurology. 95 (15): e2056–e2064. doi:10.1212/WNL.0000000000010602. ISSN 1526-632X. PMC 7713750. PMID 32759188.
  6. Hunter, Sally; Hokkanen, Suvi R. K.; Keage, Hannah A. D.; Fleming, Jane; Minett, Thais; Polvikoski, Tuomo; Allinson, Kieren; Brayne, Carol; Cambridge City over 75s Cohort collaboration (2020). "TDP-43 Related Neuropathologies and Phosphorylation State: Associations with Age and Clinical Dementia in the Cambridge City over-75s Cohort". Journal of Alzheimer's Disease. 75 (1): 337–350. doi:10.3233/JAD-191093. ISSN 1875-8908. PMID 32280087. S2CID 215748586.
  7. Karanth, Shama; Nelson, Peter T.; Katsumata, Yuriko; Kryscio, Richard J.; Schmitt, Frederick A.; Fardo, David W.; Cykowski, Matthew D.; Jicha, Gregory A.; Van Eldik, Linda J.; Abner, Erin L. (2020-10-01). "Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults". JAMA Neurology. 77 (10): 1299–1307. doi:10.1001/jamaneurol.2020.1741. ISSN 2168-6157. PMC 7309572. PMID 32568358.
  8. Josephs, Keith A.; Whitwell, Jennifer L.; Tosakulwong, Nirubol; Weigand, Stephen D.; Murray, Melissa E.; Liesinger, Amanda M.; Petrucelli, Leonard; Senjem, Matthew L.; Ivnik, Robert J.; Parisi, Joseph E.; Petersen, Ronald C. (November 2015). "TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features". Annals of Neurology. 78 (5): 697–709. doi:10.1002/ana.24493. ISSN 1531-8249. PMC 4623932. PMID 26224156.
  9. Josephs, Keith A.; Dickson, Dennis W.; Tosakulwong, Nirubol; Weigand, Stephen D.; Murray, Melissa E.; Petrucelli, Leonard; Liesinger, Amanda M.; Senjem, Matthew L.; Spychalla, Anthony J.; Knopman, David S.; Parisi, Joseph E. (November 2017). "Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study". The Lancet. Neurology. 16 (11): 917–924. doi:10.1016/S1474-4422(17)30284-3. ISSN 1474-4465. PMC 5646369. PMID 28919059.
  10. Katsumata, Yuriko; Abner, Erin L.; Karanth, Shama; Teylan, Merilee A.; Mock, Charles N.; Cykowski, Matthew D.; Lee, Edward B.; Boehme, Kevin L.; Mukherjee, Shubhabrata; Kauwe, John S. K.; Kryscio, Richard J. (November 2020). "Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy". Acta Neuropathologica. 140 (5): 659–674. doi:10.1007/s00401-020-02211-0. ISSN 1432-0533. PMC 7572241. PMID 32797255.
  11. Karanth, Shama; Nelson, Peter T.; Katsumata, Yuriko; Kryscio, Richard J.; Schmitt, Frederick A.; Fardo, David W.; Cykowski, Matthew D.; Jicha, Gregory A.; Van Eldik, Linda J.; Abner, Erin L. (2020-10-01). "Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults". JAMA Neurology. 77 (10): 1299–1307. doi:10.1001/jamaneurol.2020.1741. ISSN 2168-6157. PMC 7309572. PMID 32568358.
  12. Nelson, Peter T. (2021-08-11). "LATE Neuropathologic Changes with Little or No Alzheimer Disease is Common and is Associated with Cognitive Impairment but Not Frontotemporal Dementia". Journal of Neuropathology and Experimental Neurology. 80 (7): 649–651. doi:10.1093/jnen/nlab050. ISSN 1554-6578. PMC 8357339. PMID 34270750.
  13. Amador-Ortiz, Catalina; Ahmed, Zeshan; Zehr, Cynthia; Dickson, Dennis W. (March 2007). "Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration". Acta Neuropathologica. 113 (3): 245–252. doi:10.1007/s00401-006-0183-4. ISSN 0001-6322. PMC 1794627. PMID 17195931.
  14. Josephs, Keith A.; Murray, Melissa E.; Whitwell, Jennifer L.; Tosakulwong, Nirubol; Weigand, Stephen D.; Petrucelli, Leonard; Liesinger, Amanda M.; Petersen, Ronald C.; Parisi, Joseph E.; Dickson, Dennis W. (April 2016). "Updated TDP-43 in Alzheimer's disease staging scheme". Acta Neuropathologica. 131 (4): 571–585. doi:10.1007/s00401-016-1537-1. ISSN 1432-0533. PMC 5946692. PMID 26810071.
  15. 1 2 Amador-Ortiz, Catalina; Lin, Wen-Lang; Ahmed, Zeshan; Personett, David; Davies, Peter; Duara, Ranjan; Graff-Radford, Neill R.; Hutton, Michael L.; Dickson, Dennis W. (May 2007). "TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease". Annals of Neurology. 61 (5): 435–445. doi:10.1002/ana.21154. ISSN 0364-5134. PMC 2677204. PMID 17469117.
  16. Nelson, Peter T.; Abner, Erin L.; Schmitt, Frederick A.; Kryscio, Richard J.; Jicha, Gregory A.; Smith, Charles D.; Davis, Daron G.; Poduska, John W.; Patel, Ela; Mendiondo, Marta S.; Markesbery, William R. (January 2010). "Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons". Brain Pathology (Zurich, Switzerland). 20 (1): 66–79. doi:10.1111/j.1750-3639.2008.00244.x. ISSN 1750-3639. PMC 2864342. PMID 19021630.
  17. Dickson, D. W.; Davies, P.; Bevona, C.; Van Hoeven, K. H.; Factor, S. M.; Grober, E.; Aronson, M. K.; Crystal, H. A. (1994). "Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans". Acta Neuropathologica. 88 (3): 212–221. doi:10.1007/BF00293396. ISSN 0001-6322. PMID 7810292. S2CID 6265307.
  18. Hokkanen, Suvi R. K.; Hunter, Sally; Polvikoski, Tuomo M.; Keage, Hannah A. D.; Minett, Thais; Matthews, Fiona E.; Brayne, Carol; MRC CFAS and CC75C Study Group (July 2018). "Hippocampal sclerosis, hippocampal neuron loss patterns and TDP-43 in the aged population". Brain Pathology (Zurich, Switzerland). 28 (4): 548–559. doi:10.1111/bpa.12556. ISSN 1750-3639. PMC 6099461. PMID 28833898.
  19. Spina, Salvatore; La Joie, Renaud; Petersen, Cathrine; Nolan, Amber L.; Cuevas, Deion; Cosme, Celica; Hepker, Mackenzie; Hwang, Ji-Hye; Miller, Zachary A.; Huang, Eric J.; Karydas, Anna M. (2021-08-17). "Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease". Brain: A Journal of Neurology. 144 (7): 2186–2198. doi:10.1093/brain/awab099. ISSN 1460-2156. PMC 8502474. PMID 33693619.
  20. Zarow, Chris; Weiner, Michael W.; Ellis, William G.; Chui, Helena Chang (July 2012). "Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample". Brain and Behavior. 2 (4): 435–442. doi:10.1002/brb3.66. ISSN 2162-3279. PMC 3432966. PMID 22950047.
  21. Makkinejad, Nazanin; Schneider, Julie A.; Yu, Junxiao; Leurgans, Sue E.; Kotrotsou, Aikaterini; Evia, Arnold M.; Bennett, David A.; Arfanakis, Konstantinos (May 2019). "Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults". Neurobiology of Aging. 77: 104–111. doi:10.1016/j.neurobiolaging.2019.01.022. ISSN 1558-1497. PMC 6486844. PMID 30784812.
  22. Nelson, Peter T.; Schmitt, Frederick A.; Lin, Yushun; Abner, Erin L.; Jicha, Gregory A.; Patel, Ela; Thomason, Paula C.; Neltner, Janna H.; Smith, Charles D.; Santacruz, Karen S.; Sonnen, Joshua A. (May 2011). "Hippocampal sclerosis in advanced age: clinical and pathological features". Brain: A Journal of Neurology. 134 (Pt 5): 1506–1518. doi:10.1093/brain/awr053. ISSN 1460-2156. PMC 3097889. PMID 21596774.
  23. Dickson, Dennis W.; Baker, Matthew; Rademakers, Rosa (2010). "Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly". Neuro-Degenerative Diseases. 7 (1–3): 170–174. doi:10.1159/000289231. ISSN 1660-2862. PMC 2859236. PMID 20197700.
  24. Murray, Melissa E.; Cannon, Ashley; Graff-Radford, Neill R.; Liesinger, Amanda M.; Rutherford, Nicola J.; Ross, Owen A.; Duara, Ranjan; Carrasquillo, Minerva M.; Rademakers, Rosa; Dickson, Dennis W. (September 2014). "Differential clinicopathologic and genetic features of late-onset amnestic dementias". Acta Neuropathologica. 128 (3): 411–421. doi:10.1007/s00401-014-1302-2. ISSN 1432-0533. PMC 4412022. PMID 24899141.
  25. Nelson, Peter T.; Estus, Steven; Abner, Erin L.; Parikh, Ishita; Malik, Manasi; Neltner, Janna H.; Ighodaro, Eseosa; Wang, Wang-Xia; Wilfred, Bernard R.; Wang, Li-San; Kukull, Walter A. (2014). "ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology". Acta Neuropathologica. 127 (6): 825–843. doi:10.1007/s00401-014-1282-2. ISSN 1432-0533. PMC 4113197. PMID 24770881.
  26. Dugan, Adam J.; Nelson, Peter T.; Katsumata, Yuriko; Shade, Lincoln M. P.; Boehme, Kevin L.; Teylan, Merilee A.; Cykowski, Matthew D.; Mukherjee, Shubhabrata; Kauwe, John S. K.; Hohman, Timothy J.; Schneider, Julie A. (2021-09-15). "Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study". Acta Neuropathologica Communications. 9 (1): 152. doi:10.1186/s40478-021-01250-2. ISSN 2051-5960. PMC 8442328. PMID 34526147.
  27. Yang, Hyun-Sik; Yu, Lei; White, Charles C.; Chibnik, Lori B.; Chhatwal, Jasmeer P.; Sperling, Reisa A.; Bennett, David A.; Schneider, Julie A.; De Jager, Philip L. (September 2018). "Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study". The Lancet. Neurology. 17 (9): 773–781. doi:10.1016/S1474-4422(18)30251-5. ISSN 1474-4465. PMC 6154505. PMID 30093249.
  28. Beecham, Gary W.; Hamilton, Kara; Naj, Adam C.; Martin, Eden R.; Huentelman, Matt; Myers, Amanda J.; Corneveaux, Jason J.; Hardy, John; Vonsattel, Jean-Paul; Younkin, Steven G.; Bennett, David A. (September 2014). "Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias". PLOS Genetics. 10 (9): e1004606. doi:10.1371/journal.pgen.1004606. ISSN 1553-7404. PMC 4154667. PMID 25188341.
  29. Dugan, Adam J.; Nelson, Peter T.; Katsumata, Yuriko; Shade, Lincoln M. P.; Teylan, Merilee A.; Boehme, Kevin L.; Mukherjee, Shubhabrata; Kauwe, John S. K.; Hohman, Timothy J.; Schneider, Julie A.; Alzheimer's Disease Genetics Consortium (2021-10-29). "Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes". Neurobiology of Aging. doi:10.1016/j.neurobiolaging.2021.10.011. ISSN 0197-4580. PMID 34852950. S2CID 240120472.
  30. Chen, Han-Jou; Mitchell, Jacqueline C. (2021-06-02). "Mechanisms of TDP-43 Proteinopathy Onset and Propagation". International Journal of Molecular Sciences. 22 (11): 6004. doi:10.3390/ijms22116004. ISSN 1422-0067. PMC 8199531. PMID 34199367.
  31. Gendron, Tania F.; Rademakers, Rosa; Petrucelli, Leonard (2013). "TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43". Journal of Alzheimer's Disease. 33 Suppl 1: S35–45. doi:10.3233/JAD-2012-129036. ISSN 1875-8908. PMC 3532959. PMID 22751173.
  32. 1 2 Neumann, Manuela; Sampathu, Deepak M.; Kwong, Linda K.; Truax, Adam C.; Micsenyi, Matthew C.; Chou, Thomas T.; Bruce, Jennifer; Schuck, Theresa; Grossman, Murray; Clark, Christopher M.; McCluskey, Leo F. (2006-10-06). "Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis". Science. 314 (5796): 130–133. Bibcode:2006Sci...314..130N. doi:10.1126/science.1134108. ISSN 1095-9203. PMID 17023659. S2CID 8620103.
  33. "Newly recognized form of dementia could now be easier to diagnose". New Scientist. 30 April 2019. Retrieved 30 April 2019.
  34. Chornenkyy, Yevgen; Fardo, David W.; Nelson, Peter T. (July 2019). "Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy". Laboratory Investigation. 99 (7): 993–1007. doi:10.1038/s41374-019-0196-y. ISSN 1530-0307. PMC 6609463. PMID 30742063.

Further reading

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.